WHAT WE DO
Improving cervical cancer
prevention worldwide

Our vision

ETiCCS works to ensure that every woman, everywhere, has access to accurate, timely, and high-quality cervical cancer screening and care — regardless of where she lives or what resources are available.

Our vision is built on four guiding principles:

To Reach All
Access to cervical cancer screening should not depend on geography or socioeconomic status.

Our goal is to ensure that all women, including those in remote or underserved regions, can be screened at least once during the highest-impact age window (30–49 years).
To Deliver High Quality, Standardized Care
Every woman deserves the same level of quality and safety.

We implement scientifically proven, cost-effective screening and triage pathways that raise the standard of care across all settings and reduce loss to follow-up.
Empower Health Workers Through Technology
We use AI-supported tools, digital diagnostics, and mobile solutions to assist clinicians, improve accuracy, and streamline workflows.

Technology helps reduce the burden on overstretched health systems and ensures that women in need receive timely treatment.
Build Sustainable, Scalable Systems
Our model is designed to be replicable at national scale.

By strengthening local health services, integrating digital platforms, and collaborating with industry and national partners, we create solutions that are durable, efficient, and adaptable to different countries.

Why we do it

Cervical cancer is preventable
Cervical cancer remains a major global health burden. Although deaths from cervical cancer are largely preventable, the disease continues to affect women worldwide — especially in regions with limited access to screening and treatment.

Every year, more than half a million women are diagnosed, and many cases are found too late, when treatment is more difficult or unavailable.

It is preventable with timely vaccination and efficient screening.

Two tools can dramatically reduce the burden of cervical cancer:
- HPV vaccination, which prevents the majority of high-risk infections
  
  Screening programs, which detect changes early, before cancer develops
Countries with organized screening programs — such as many in Europe and North America — have reduced cervical cancer rates by up to 80%. This demonstrates what is possible when screening is accessible, reliable, and well implemented.
cervical cancer is a disease of disparity and poverty
In many parts of the world — across Africa, Asia, Latin America, Eastern Europe, and rural regions everywhere — women still face:
- Few or no opportunities to be screened even once in their lifetime
- Long travel distances to clinics
- Overstretched health systems and limited diagnostic capacity
- Late diagnosis, often when symptoms finally appear
- Barriers due to cost, stigma, or lack of information
Cervical cancer is therefore a disease of inequality, not inevitability. Women with fewer resources have a much higher likelihood of developing and dying from a disease that is highly preventable.
technology can change this
Advances in health technology now make it possible to deliver accurate screening, even in areas with limited resources:
- High-precision HPV tests
- Self-sampling methods
- Digital tools for triage
- AI-supported image evaluation
- Mobile platforms for follow-up and data management
These innovations help health workers, reduce system burdens, and ensure that women receive timely care.
our purpose
We work to ensure that no woman’s health outcome depends on where she lives.

By combining proven prevention strategies with modern digital tools, we help countries build screening programs that are effective, reachable, and equitable — so that cervical cancer becomes a rare disease everywhere, not only in high-income regions.

How we do it

We apply a standardized, evidence-based screening pathway that can be adapted to different countries and populations while keeping the same core structure. This ensures quality, safety, data protection, and scalability everywhere we work.

Our approach follows international best practices and supports countries in progressing toward the WHO 2030 cervical cancer elimination goals.

HOW WE DO IT

Community Awareness & Enrollment

Together with local health facilities and partners, women are informed about cervical cancer, its prevention, and available screening options.

Eligible participants are registered, and basic health information is collected electronically.

HPV Testing as the Primary Screening Method

We use HPV testing as the main screening strategy, which is the international gold standard.

Depending on the setting and women’s preferences, the test can be done through:

– Self-sampling, allowing privacy and reaching women who rarely attend clinics

– Provider-collected samples, performed by trained nurses or midwives

All samples follow the same standardized processing pathway.

Laboratory Processing & Triage

Cervical samples are sent to a designated local or regional laboratory for:

– High-risk HPV testing

– Biomarker or cytology-based triage, such as CINtec Plus or other validated methods

– Biopsy collection for women with high-risk results, if required

These steps ensure that only women who truly need further evaluation are referred, reducing the burden on health systems and patients.

Digital Data Management Through OncoPath

All data flows through our secure, cloud-based digital platform, OncoPath, developed with PAiCON.

The platform ensures:

– Secure storage of patient data

– A seamless link between patients, clinics, and laboratories

– Automated result tracking and follow-up reminders

– Standardized workflows across all countries

– Offline functionality, which is essential in rural and low-connectivity regions

OncoPath supports health workers in delivering timely care and minimizing loss to follow-up.

AI-Assisted Clinical Support

Within OncoPath, we are currently developing and integrating an AI-assisted image evaluation tool to help healthcare workers identify cervical lesions more accurately.

This supports clinicians in decision-making, improves diagnostic consistency, and strengthens systems where specialists are limited.

Communication of Results & Follow-Up

Women are informed of their results through the most accessible method — SMS, phone call, or home visit.

Those requiring further tests or treatment receive clear guidance and are scheduled promptly.

Quality Assurance & Long-Term Tracking

All screening results are stored in an anonymized (de-linked) form to support quality assurance, monitoring, and future program planning.

This enables countries to scale up screening nationally using a sustainable, data-driven model.

Screening process at-a-glance

1. Community Concern

Community talks about health issues including cervical cancer (CC).

2. Community Mobilisation

Community health workers inform about CC program during time limited campaign.

3. Household screening visit

At home visit during screening campaign, woman self-collects a sample for HPV testing

Health worker carries self-sample registered on e-tablet

4. Laboratory investigation

At laboratory, lab technician performs HPV test on self-sample

5. Delivery of results

Patient gets notified by cellphone about HPV result

6. Walk to clinic

HPV-positive patient has an appointment at the clinic

7. Clinic visit

HPV-positive patient gets examined and, when necessary, treated

8. Screening completed

Patient has successfully completed the screening process

Current Status and future plans

Global Implementation Achievements
Over the past years, we have successfully implemented our standardized cervical cancer screening approach in several countries, including Ethiopia, Kenya, Namibia, and Cambodia. These partnerships have demonstrated that a digital, HPV-based screening program can operate effectively across diverse health systems and resource settings.

We are now expanding this work to Kosovo and Albania, where implementation is currently underway. In each setting, our focus remains the same: establishing a sustainable, technology-supported screening model that strengthens local healthcare systems and ensures high-quality prevention for all women.
Vision for Expansion and Future Collaboration
Looking ahead, our priority is to build new partnerships worldwide. We are fully prepared to support countries wishing to adopt our method, integrate digital tools into their screening programs, and progress toward the global goal of eliminating cervical cancer as a public health problem.

Our experience across continents shows that when accurate screening, trained health workers, and modern technology come together, cervical cancer prevention becomes accessible, scalable, and achievable for every country.

PARTNER WITH US

WHAT WE DO
Improving cervical cancer
prevention worldwide

Our vision »

Why we do it »

How we do it »

Current status and future plans »

Our vision

To Reach All

To Deliver High Quality, Standardized Care

Empower Health Workers Through Technology

Build Sustainable, Scalable Systems

Why we do it

Cervical cancer is preventable

cervical cancer is a disease of disparity and poverty

technology can change this

our purpose